TSA also reduces neurotoxicity in α-synuclein overexpressing Drosophila models of PD, improving locomotor impairment, and reducing early mortality rates [114,116], as well as promoting H3 acetylation-mediated GDNF upregulation in astrocytes [168,185,186]. This evidence concerns the gene SNCA and Parkinson disease.